Bupivacaine Hydrochloride Injection, Solution
Product Images NDC 55150-167

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Bupivacaine Hydrochloride (NDC 55150-167). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (0.25% 25 mg/10 mL (2.5 mg/mL))

Bupivacaine Hydrochloride Injection, USP 0.25% (2.5 mg/mL), 25 mg per 10 mL single-dose vial. The label states it is preservative-free and intended for infiltration, nerve block, caudal, and epidural anesthesia, but not for spinal anesthesia. Distributed by AuroMedics Pharma LLC, made in India, with storage instructions and sterility information included.*

FDA Label Image

Package Label-principal Display Panel (0.75% 75 mg/10 mL (7.5 mg/mL))

Packaging label for Bupivacaine Hydrochloride 0.75% injection solution (7.5 mg/mL). The box contains 25 single-dose vials of 10 mL each, labeled for epidural and retrobulbar anesthesia but not for obstetric or spinal anesthesia. The product is preservative-free and distributed by AuroMedics Pharma LLC, made in India.*

FDA Label Image

Package Label-principal Display Panel (0.75% 225 mg/30 mL (7.5 mg/mL))

Label for Bupivacaine Hydrochloride Injection, USP 0.75% (7.5 mg/mL) in a 30 mL single-dose vial, totaling 225 mg per vial. The label indicates use for epidural and retrobulbar anesthesia, not for obstetric or spinal anesthesia, and notes it is preservative-free. Distributed by AuroMedics Pharma LLC, the label includes storage instructions and manufacturing origin as India.*

FDA Label Image

Package Label-principal Display Panel (0.75% 225 mg/30 mL (7.5 mg/mL))

Carton label for Bupivacaine Hydrochloride 0.75% (7.5 mg/mL) injection, USP, with a total of 225 mg per 30 mL. The product is preservative free and intended for epidural and retrobulbar anesthesia, not for obstetric or spinal anesthesia. The label indicates single-dose vials in a 25 x 30 mL package, distributed by AuroMedics Pharma LLC. It includes storage instructions and a barcode.*

FDA Label Image

Package Label-principal Display Panel (0.25% 25 mg/10 mL (2.5 mg/mL))

Packaging label for Bupivacaine Hydrochloride 0.25% (2.5 mg/mL) injection, USP by Auromedics, distributed by AuroMedics Pharma LLC. The label shows 25 mg per 10 mL (2.5 mg/mL) strength in 25 single-dose 10 mL vials. Indicated for infiltration, nerve block, caudal, and epidural anesthesia, not for spinal anesthesia. It is preservative free and sterile, with storage instructions and drug facts included.*

FDA Label Image

Package Label-principal Display Panel (0.25% 75 mg/30 mL (2.5 mg/mL))

Label for Bupivacaine Hydrochloride Injection, USP, 0.25% strength (2.5 mg/mL), 75 mg per 30 mL in a single dose vial. The product is indicated for infiltration, nerve block, caudal, and epidural anesthesia but not for spinal anesthesia. The label states it is preservative-free and includes storage instructions and distributor information for AuroMedics Pharma LLC. The labeler is Auromedics.*

FDA Label Image

Package Label-principal Display Panel (0.25% 75 mg/30 mL (2.5 mg/mL))

Packaging label for Bupivacaine Hydrochloride Injection USP 0.25% (2.5 mg/mL) by Auromedics Pharma LLC. The label indicates a 75 mg per 30 mL (2.5 mg/mL) solution in single-dose vials, preservative free, for infiltration, nerve block, caudal, and epidural anesthesia but not for spinal anesthesia. The package contains 25 x 30 mL single-dose vials and notes storage instructions and manufacturer's address in Windsor, NJ.*

FDA Label Image

Package Label-principal Display Panel (0.5% 50 mg/10 mL (5 mg/mL))

Label for Bupivacaine Hydrochloride Injection, USP 5 mg/mL (50 mg per 10 mL) in a 10 mL single-dose vial. The product is preservative-free and intended for nerve block, caudal, and epidural anesthesia but not for spinal anesthesia. Distributed by AuroMedics Pharma LLC, made in India, with storage instructions and sterile, nonpyrogenic designation.*

FDA Label Image

Package Label-principal Display Panel (0.5% 50 mg/10 mL (5 mg/mL))

Packaging label for Bupivacaine Hydrochloride 0.5% (5 mg/mL) injection, USP. The box contains 25 single-dose vials of 10 mL each, labeled for nerve block, caudal, and epidural anesthesia but not for spinal anesthesia. The label indicates the product is preservative-free, sterile, nonpyrogenic, and distributed by AuroMedics Pharma LLC. Storage and usage instructions are also included.*

FDA Label Image

Package Label-principal Display Panel (0.5% 150 mg/30 mL (5 mg/mL))

Label for Bupivacaine Hydrochloride Injection USP 5 mg/mL solution, 150 mg per 30 mL vial. The label notes 0.5% concentration, for nerve block, caudal, and epidural anesthesia, not for spinal anesthesia. It is preservative free and a single-dose 30 mL vial. Distributed by AuroMedics Pharma LLC, made in India.*

FDA Label Image

Package Label-principal Display Panel (0.5% 150 mg/30 mL (5 mg/mL))

Packaging label for Bupivacaine HCl Injection, USP 0.5% (5 mg/mL), 150 mg per 30 mL solution. The label indicates the product is preservative-free, for nerve block, caudal, and epidural anesthesia, but not for spinal anesthesia. The package contains 25 single-dose vials of 30 mL each, labeled by Auromedics and distributed by AuroMedics Pharma LLC, made in India.*

FDA Label Image

Package Label-principal Display Panel (0.75% 75 mg/10 mL (7.5 mg/mL))

Label for Bupivacaine Hydrochloride Injection, USP 0.75% (7.5 mg/mL) in a 10 mL single-dose vial. The label indicates use for epidural and retrobulbar anesthesia, stating it is preservative-free and not for obstetric or spinal anesthesia. Distributed by AuroMedics Pharma LLC with storage instructions and a barcode included.*

FDA Label Image

Chemical Structure (Bupivacaine Str)

Chemical structure of Bupivacaine Hydrochloride depicting its molecular components, including a morpholine ring, an amide linkage, aromatic ring with dimethyl substitutions, and associated hydrochloride and water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.